Effects (MACE and bleeding events) of ticagrelor combined with omeprazole on patients with acute myocardial infarction undergoing primary PCI

O'Gara, 2013, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 61, e78, 10.1016/j.jacc.2012.11.019 Kassimis, 2017, Percutaneous coronary intervention vs. cardiac surgery in diabetic patients. Where are we now and where should we be going?, Hellenic J Cardiol, 58, 178, 10.1016/j.hjc.2017.01.028 Windecker, 2014, Eur Heart J, 35, 2541, 10.1093/eurheartj/ehu278 Dunn, 2013, Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials, J Am Heart Assoc, 2 Shah, 2015, Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population, PLoS One, 10, 10.1371/journal.pone.0124653 Wang, 2014, Prognosis of concomitant users of clopidogrel and proton-pump inhibitors in a high-risk population for upper gastrointestinal bleeding, BMC Pharmacol Toxicol, 15 Tantry, 2013, Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding, J Am Coll Cardiol, 62, 2261, 10.1016/j.jacc.2013.07.101 Yao, 2017, Comparative study of ticagrelor and clopidogrel in therapeutic effect of acute myocardial infarction patients undergoing percutaneous coronary intervention, Saudi J Biol Sci, 24, 1818, 10.1016/j.sjbs.2017.11.020 Gao, 2018, Safety and Incidence of Cardiovascular Events in Chinese Patients with Acute Coronary Syndrome Treated with Ticagrelor: the 12-Month, Phase IV, Multicenter, Single-Arm DAYU Study, Cardiovasc Drugs Ther, 32, 47, 10.1007/s10557-018-6772-3 Lee, 2018, Impact of Ticagrelor in Patients With Prior MI and MVD for Reducing Cardiovascular Events, J Am Coll Cardiol, 71, 497, 10.1016/j.jacc.2017.11.049 Xanthopoulou, 2018, Absence of differential effect of ticagrelor versus prasugrel maintenance dose on endothelial function in patients with stable coronary artery disease, Hellenic J Cardiol, 59, 338, 10.1016/j.hjc.2017.12.008 Maggio, 2013, Proton pump inhibitors and risk of 1-year mortality and rehospitalization in older patients discharged from acute care hospitals, JAMA Intern Med, 173, 518, 10.1001/jamainternmed.2013.2851 O'Donoghue, 2009, Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials, Lancet, 374, 989, 10.1016/S0140-6736(09)61525-7 Thongprayoon, 2017, Persistent acute kidney injury following transcatheter aortic valve replacement, J Card Surg, 32, 550, 10.1111/jocs.13200 Upadhaya, 2017, Drug-eluting stent placement versus coronary artery bypass surgery for unprotected left main coronary artery disease: A meta-analysis of randomized controlled trials, J Card Surg, 32, 70, 10.1111/jocs.13090 Marmagkiolis, 2018, Efficacy and safety of routine aspiration thrombectomy during primary PCI for ST-segment elevation myocardial infarction: A meta-analysis of large randomized controlled trials, Hellenic J Cardiol, 59, 168, 10.1016/j.hjc.2017.09.003 Hu, 2017, Neuroprotective strategies for patients with acute myocardial infarction combined with hypoxic ischemic encephalopathy in the ICU, Hellenic J Cardiol, 58, 427, 10.1016/j.hjc.2016.12.006